Up to 40% of abdominal aortic aneurysms (AAAs) are associated with a common iliac artery aneurysm (IAA). [1] [2] [3] [4] Endovascular repair of these synchronous aneurysms requires internal iliac artery (IIA) embolization and exclusion or preservation of IIA flow with novel techniques.
Embolization of the IIA with extension of the limb into the external iliac artery (EIA) can lead to pelvic or buttock ischemia. [5] [6] [7] [8] Although unilateral IIA embolization can have relatively low rates of complications, 7 they can result in devastating sequelae, including buttock claudication (28%-42%), impotence (17%-24%), colonic ischemia (3.4%), and spinal cord ischemia (0.1%-0.3%), particularly if bilateral embolization is necessary. 9, 10 In addition, despite hypogastric coiling or coverage, type II endoleak can occur from retrograde hypogastric perfusion. 11, 12 Different techniques have been used to preserve blood flow into the IIA to avoid these complications. These include surgical correction of the iliac bifurcation 13 ;
surgeon-modified iliac stent graft components 14 ;
aortouni-iliac endografting with contralateral EIA to hypogastric artery stent graft 15 ; double barrel, snorkel, and sandwich parallel endografts [16] [17] [18] ; and trifurcated endografts. 19, 20 Each of these techniques requires The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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Copyright IIA embolization and exclusion or other complicated techniques to maintain IIA perfusion are not ideal options. However, before FDA approval of the Gore IBE device, there were no other options to preserve perfusion to the IIA. We describe a technique with the off-label use of a minimally altered off-the-shelf bifurcated graft in the common iliac artery (CIA) to maintain IIA perfusion (Fig 1) in 14 patients and the early results.
METHODS
Approval was obtained from the Institutional Review Board of the University of Washington Human Subjects Division for a retrospective chart review of all patients who had undergone bifurcated-bifurcated repair. All patients were evaluated with a computed tomography angiography (CTA) scan, and IAAs $3.5 cm or with $0.5 cm of growth in 6 months or with concomitant AAA were considered for repair. Those matching inclusion anatomic criteria (Table I) were considered for a bifurcated-bifurcated repair. Informed consent, including the unknown long-term outcome of the device, was obtained from all patients. All patients accepted to have the bifurcated-bifurcated repair as opposed to the loss of perfusion to an IIA. Fourteen consecutive male patients underwent IAA repair with a bifurcated-bifurcated approach from August 2009 to May 2015. During the same period, the same surgeon performed 12 standard endovascular aneurysm repairs (EVARs) with IIA embolization and extension of the limb into the EIA. The procedures were performed under general anesthesia and a completely percutaneous approach. The first eight cases were performed in the operating suite with a C-arm. In October 2013, a hybrid operating room was implemented in our facility, and the remaining six cases were performed with fixed imaging (Artis Q zeego; Siemens Medical Solutions USA, Inc, Malvern, Pa).
Iliac aneurysm bifurcated repair. The procedures began with ultrasound-guided access to the common femoral arteries with placement of 6F sheaths. The patients were systemically heparinized and serial activated clotting times monitored. The arteriotomies were then preclosed with Prostar XL (Abbott Vascular, Abbott Park, Ill) devices. A 22-mm or 24-mm Cook Zenith bifurcated device was selected on the basis of the patient's anatomy. These devices were unsheathed and altered on the back operative table by removing the top uncovered stent by dividing the graft using ophthalmologic fine-tip cautery, leaving the graft intact and the sutures securing the top covered stent undisturbed. The grafts were resheathed and advanced through the femoral artery ipsilateral to the intended side of IIA preservation. The bifurcated device was deployed in the CIA with the contralateral gate directed to the IIA (Fig 2, A) . The device was deployed below the level of the aortic bifurcation, facilitating access "up and over" the aortic bifurcation from the contralateral femoral artery. A hydrophilic wire was advanced through the femoral artery and snared from the contralateral femoral artery (Fig 2, B) to establish a through-and-through femoral-femoral wire (Fig 2, C) . This was switched out to a stiff wire to allow placement of a 12F braided sheath up and over the aortic bifurcation from the contralateral femoral artery into the main body of the bifurcated iliac stent graft, which was supported by a Coda balloon (Cook) if there was difficulty going over the aortic bifurcation (Fig 2, D) . This was then used as a stable platform to select the contralateral gate of the bifurcated iliac stent graft into the IIA (Fig 2, E) and to place a stent graft (Gore Viabahn 13-Â 5-cm endoprosthesis) into the IIA (Fig 2, F) , ideally with 1.5 cm of seal within the IIA.
Infrarenal AAA repair. The bifurcated main body device was then advanced through the contralateral femoral artery and deployed with the contralateral gate directed toward the iliac bifurcated device (Fig 2, G) . The contralateral gate was cannulated and a flared bridging stent placed between the aortic contralateral gate and the main body of the iliac bifurcated device, achieving an overlap between the devices of 17 mm, the length of the sealing stent of the flared limb (Fig 2, H) . The then extended with an iliac extension limb to either the CIA or the EIA (with IIA embolization and exclusion if patent) on the contralateral side and the EIA on the side of the iliac bifurcated graft (Fig 2, I ). The preclose sutures placed at the beginning of the procedure were used to close the arteriotomies bilaterally.
Final imaging. For completion imaging, on-table DynaCTA (Siemens) was performed to evaluate for graft placement and positioning.
Evolution of the procedure. For the first three procedures, brachial artery access was included in the operative plan to select the contralateral gate of the iliac bifurcated device. For the remaining procedures, an adjustment was made with the through-and-through femoral-femoral wire, allowing an up-and-over sheath from the contralateral groin. This created a stable platform into the iliac bifurcated graft and allowed selection of the IIA and the passage and deployment of the covered stent into the IIA. This has obviated the need for brachial artery access, although this is still an option if the through-and-through femoral-femoral wire and sheath are unsuccessful.
Postoperative care. These patients were treated under our protocol for standard endovascular elective repair of AAAs with overnight observation in the intensive care unit and discharge when stable. 
RESULTS
From August 2009 to May 2015, 14 patients with IAAs underwent repair with a bifurcated-bifurcated approach. A 22-mm or 24-mm bifurcated main body device was used in the CIA ipsilateral to the IAA with extension of the "contralateral" limb into the IIA.
Patients. All 14 patients undergoing bifurcatedbifurcated repair were male and had the usual comorbidities (Table II) . Each of our patients presented with AAA with IAA or bilateral IAAs (Table III) . Ten patients presented with an AAA with a mean diameter of 4.4 cm (3.1-6.1 cm). One patient had previously undergone EVAR with successful AAA exclusion. Eleven patients had bilateral IAAs, and the remaining two patients had an AAA with a unilateral IAA. The maximum IAA mean diameter of each patient's largest IAA was 4.0 cm (2.9-5 cm).
Operative details. Perfusion to one IIA was preserved in 13 of the 14 patients with 93% technical success. In one case, the IIA was patent but diminutive on preoperative CTA but was thrombosed at the time of the procedure and could not be selected. In this case, a standard Key steps in bifurcated-bifurcated repair. A, The bifurcated graft deployed in the aneurysmal common iliac artery (CIA) with the contralateral gate directed to the internal iliac artery (IIA). B and C, A hydrophilic wire advanced through the contralateral femoral artery and snared from the ipsilateral femoral artery to establish a through-and-through femoral-femoral wire. D, A stiff through-and-through wire is used to allow placement of a 12F braided sheath up and over the aortic bifurcation from the contralateral femoral artery into the main body of the bifurcated iliac stent graft (with the option of a Coda balloon in the aorta for support as seen in E and F). The contralateral gate of the bifurcated iliac stent graft and the IIA are selected and catheterized for placement of a stent graft (Gore Viabahn 13-mm endoprosthesis) . G, The bifurcated main body device advanced through the contralateral femoral artery and deployed with the contralateral gate directed toward the iliac bifurcated device. H, A bridging stent placed between the aortic contralateral gate and the main body of the iliac bifurcated device. I, The limb extended to the contralateral CIA and the external iliac artery (EIA) on the side of the iliac bifurcated graft.
EVAR was performed with extension of that limb into the ipsilateral EIA. One patient had a previous EVAR and on postoperative surveillance presented with an IAA that had grown to a size greater than the threshold for repair. In another case, the anatomy precluded a bifurcated-bifurcated repair, and aneurysm repair proceeded with a planned aortouni-iliac aortic aneurysm repair with a bifurcated iliac repair and open femoral-femoral bypass. On preoperative CTA, because of the presence of a hairpin turn of the contralateral EIA, it was determined that delivery of the endograft would not be possible. In a third case, the aortic aneurysm was a juxtarenal aneurysm and required a fenestrated repair in combination with bifurcated-bifurcated repair with a fenestration for the superior mesenteric artery and branches for the renal arteries.
Procedure time, fluoroscopy time, contrast agent volume, and length of stay (intensive care unit and total hospital) are similar compared with uncomplicated EVAR (Table IV) . There were three cases with an operative time in excess of 3 hours, the fenestrated bifurcatedbifurcated repair and the first two procedures when the bifurcated-bifurcated technique was first performed. Contrast agent volume used initially decreased with experience with bifurcated-bifurcated repair but increased again in the later years because of use of completion on-table DynaCTA. Percutaneous femoral access was possible with preclosure with the Prostar XL device in 92% of cases attempted (12/13), with the failure of the preclosure devices in one patient. Open femoral access was used in the single case of planned aortouniiliac aortic aneurysm repair with femoral-femoral bypass.
Outcomes. The average follow-up of the patients was 31.6 months (median, 19.4 months) with ultrasound or CTA and an office visit. One patient was lost to follow-up after the 1-month visit, but the remaining patients were all observed for at least 1 year. Some patients had been originally referred from community vascular surgeons and continued their follow-up with their own vascular surgeon with records forwarded after each visit. One patient died 28.8 months after repair, but the details of his death are unknown because he was lost to follow-up. Two patients required reintervention. The first patient presented to his first follow-up visit on postoperative day 25 with new-onset claudication and thrombosis of the right external iliac limb ipsilateral to the bifurcated iliac repair. He was taken semielectively for thrombectomy and stenting of the limb. This same patient presented at 83 months with growth of the preserved IIA to 3.9 cm and underwent coil embolization of the aneurysm. The second patient presented for surveillance 44 months after his original bifurcated-bifurcated repair with a type III endoleak with component separation of the mating stent and the iliac bifurcated stent grafts. This was treated successfully with a limb extension and endoanchors to fuse the endografts.
Three patients had a type II endoleak on initial imaging, but none were clinically significant; two resolved during the first year, and the third persisted at 14 months but without sac growth. There were no cases of clinically significant bowel ischemia or erectile dysfunction. One patient had classic buttock claudication at 1-and 3-month follow-up, but it had resolved by his 6-month follow-up. This patient had bilateral IAAs, and the claudication occurred on the side of IIA coil embolization (contralateral to bifurcated iliac repair and preserved IIA).
Of the 13 patients who underwent bifurcatedbifurcated repair, 100% of the preserved IIAs remained patent at last follow-up. The composite outcome measure of IIA patency and freedom from reintervention and clinically significant endoleak at 1 year was 92% (n ¼ 12/13).
DISCUSSION
Bifurcated-bifurcated repair of aortoiliac aneurysms is technically feasible with good short-term and midterm results. Before FDA approval of the Gore IBE device, this provided an alternative technique to preserve perfusion to the IIA when the only available solutions involved complicated hybrid approaches, significantly altered endografts, or snorkel and chimney techniques. Our technique requires minimal endograft alteration and uses a technique similar to that used for the Gore IBE device, which most endovascular surgeons are able to adopt without much difficulty, making both techniques easy to apply broadly. Perfusion to the IIA is maintained using an aortic bifurcated endograft in the IAA. It can be performed with a completely percutaneous femoral 25 The most common approach, IIA embolization, has a low risk for major complications, but in repeated series, a significant number of patients have had a decrease in quality of life because of buttock and hip claudication or erectile dysfunction. [5] [6] [7] [8] [9] [10] Both major and minor complications are more severe in those patients with bilateral IAAs requiring bilateral IIA embolization. Only one of our patients experienced transient buttock and hip claudication on the side of IIA embolization, and we had no patients with any other complications, including erectile dysfunction and ischemic colitis. Two patients required three reinterventions, one in the early postoperative period at 25 days and two at nearly 4 and 7 years after bifurcated-bifurcated repair. The first reintervention was required in a patient presenting for routine 1-month follow-up with new-onset claudication and follow-up imaging demonstrating thrombosis of the limb due to kinking within a tortuous EIA. This complication occurred before the availability and routine use of completion DynaCT and was therefore not detected intraoperatively. This was successfully treated with thrombectomy and stenting of the limb. At 83 months, the same patient's preserved IIA grew aneurysmal to a maximum diameter of 3.9 cm; IIA flow was not preserved at this time because of patient factors, and it was treated with coil embolization of the IIA aneurysm. The final reintervention involved the repair of a type III endoleak of a component separation, at 44 months, of the iliac bifurcated device and the bridging stent from the aortic bifurcated device. No specific technical basis for separation of these modular components was identified, (Table I) .
Whereas the introduction of this device into the United States market has currently decreased the indications for our technique, the advantage to this technique is the ability, in the future, to adjust and possibly modify and apply the technique to those who do not match the strict anatomic criteria necessary for the use of the Gore IBE.
To our knowledge, this is a unique approach of using a standard aortic bifurcated endograft in the repair of an IAA. It provided a readily available solution with minimal alteration of an off-the-shelf graft to preserve perfusion to the IIA while excluding the IAA. In our series, a Cook aortic bifurcated endograft was used in the iliac aneurysm, but this technique is not exclusive to the Cook endograft and could be applied to other bifurcated endografts. Certain anatomic characteristics must be present for this technique to be used, similar to the Gore IBE device. The CIA must be of adequate length and diameter to accommodate the bifurcated device. In our series, the CIA must have a flow channel diameter of at least 22 mm to accommodate at least a 22-mm bifurcated endograft. Modification of the bifurcated endograft by removing one (top uncovered stent) stent allows it to fit within a CIA with a length of at least 50 mm. Based on the contralateral gate size and available endografts (Gore Viabahn endoprosthesis), the IIA must have a diameter of 8 to 12 mm in the distal seal zone. Similarly, the EIA must have a diameter of 7 to 12 mm in the distal seal zone.
CONCLUSIONS
The outcomes with this technique are excellent. With the Gore IBE device now commercially available and other new developing technology and endografts, the indications for this approach have decreased. However, longer follow-up and careful scrutiny of developing endograft technology and comparison of our technique to standard coil embolization and off-the-shelf iliac bifurcated devices will determine the best endovascular treatment of aortoiliac aneurysm disease. 
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